FB Health Equity Stake

The Company has a 5.72% equity interest in FB Health S.p.A (FB Health), an Italy-based specialty pharma focused on neurology and psychiatry. FB Health is a growing and profitable company which distributes over ten nutraceutical and pharmaceutical products in Italy with annual sales in excess of 8 million euros. The investment in FB Health is presented at fair value in BELLUS Health’s financial statements and amounted to $957,000 as of September 30, 2016.

Share this

Sign up for email alerts

Email Address *
Enter the code shown above.